Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

Dupixent comes as a liquid solution inside prefilled, single-use injection pens or syringes. It’s given as an injection under your skin. Dupixent’s active ingredient is dupilumab, a biologic.

Dupilumab (Dupixent) blocks a protein that can lead to inflammation and weaken your skin barrier. It is not immunosuppressive, meaning it doesn't weaken your immune system, or sedating, so it won ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Dupilumab Development Program Dupilumab is being jointly developed by Regeneron and Sanofi under a global collaboration agreement. To date, dupilumab has been studied across more than 60 clinical ...

About Regeneron and Sanofi’s COPD Clinical Research Program Regeneron and Sanofi are motivated to transform the treatment paradigm of COPD by examining the role different types of inflammation play in ...

However, the high cost is a deterrent for several patients. For example, a syringe of dupilumab, which is administered through an injection once every other week, can cost around S$1,000, notes Quek.

The patient was treated with oral prednisone, at an initial dose of 40 mg, together with topical tacrolimus 0.1%. There was a good initial response, with decrease in pain and erythema. Recurrence ...

Dupilumab Dupilumab (Dupixent) is a biologic approved for people ages 6 months and older, if your atopic dermatitis cannot be controlled with topical creams. You need a prescription to get it.

For people with COPD, Dupixent is given via subcutaneous injections, at a recommended dose of 300 mg, once every other week. It is available as a single-dose prefilled syringe or prefilled pen ...

Ebglyss also provided meaningful improvements in difficult-to-treat face and hand dermatitis. Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most ...